Neuropathological studies have also shown that the LC and NBM are among the earliest sites of detectable tau pathology in AD [14, 15], and some authors suggest that tau pathology in the LC precedes the onset of first symptoms by several decades [16, 17] and may underlie the development of aberrant protein aggregates in interconnected brain regions [18, 19]. This evidence concerns the gene MAPT and Alzheimer disease.